Indoco Remedies Ltd

NSE: INDOCO · BSE: 532612 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹246.10
Market cap: ₹2,272 Cr
Revenue (annual): ₹1,845 Cr
Net profit (annual): ₹-95.14 Cr
P/E (TTM): 403.5×Sector 47.4×
Promoter holding: 58.86%+0.00% QoQ
FII holding: 1.27%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 6 Promoter Buying 5 Business Update 4 Regulatory Approval 3 Other Announcement 3 Financial Results 3 Earnings Call 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

28 Jul 2026 11:55 IST NSE

Financial Results

Indoco Remedies Q1 FY27 Results: Turns Profitable, Net Profit ₹65.4 Cr

Indoco Remedies Ltd reported revenue from operations of ₹466.2 Cr (+8.2% YoY) and net profit of ₹65.4 Cr for Q1 FY27.

Key figure: Net profit ₹65.4 Cr

Open full results → Read the filing ↗

7 May 2026 12:34 IST NSE

Financial Results

Indoco Remedies Q4 FY26 Results: Net Loss of ₹23.7 Cr, Loss Narrows

Indoco Remedies Ltd reported revenue from operations of ₹475.6 Cr (+21.9% YoY) and a net loss of ₹23.7 Cr for Q4 FY26.

Key figure: Net loss ₹23.7 Cr

Open full results → Read the filing ↗

7 May 2026 12:33 IST NSE

Financial Results

Indoco Remedies Financial Results

Indoco Remedies Limited reported Q4 FY26 results with consolidated revenues growing 26% YoY to ₹429.1 Crore. The Board recommended a dividend of ₹0.20 per share (10%) on a face value of ₹2. Growth was primarily driven by strong performance in the International Formulations business and steady API growth.

Value: ₹0.20 Cr

Read the filing ↗